Tokyo, July 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058215) titled 'Association between early response and clinical outcomes of Nivolumab + Ipilimumab combination therapy for advanced hepatocellular carcinoma: A multicenter prospective observational study' on July 1.
Study Type:
Observational
Primary Sponsor:
Institute - Fujita Health University
Condition:
Condition - Unresectable hepatocellular carcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This multicenter, prospective, observational study will enroll patients receiving nivolumab + ipilimumab combination therapy, and assess the association
between early response a...